At a glance
- Originator Japan Tobacco
- Mechanism of Action Vasopressin 1 receptor antagonists; Vasopressin V2 receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Heart failure
Most Recent Events
- 06 Jul 1998 Preclinical development for Congestive heart failure in Japan (Unknown route)